About
Sandy Zweifach is Chief Executive Officer of IMIDomics Inc. and serves as Chair and Board Member at other organizations. With over 30 years in life sciences, Zweifach has held CEO and President roles at three companies, raised more than $750 million in capital, and led mergers and acquisitions and licensing transactions valued at over $500 million, with experience spanning corporate partnerships, business development, and P&L management.
Experience
- IMIDomics Inc.Chief Executive Officercurrent2026 — presentSan Francisco Bay Area
- IMIDomics Inc.Executive Board Membercurrent2024 — presentBarcelona, Catalonia, Spain and San Francisco
- IMIDomics Inc.President, CBO and Chair BABcurrent2022 — presentUnited States
- SMART (Schools, Mentoring and Resource Team)Chairperson of the Boardcurrent2024 — presentSan Francisco Bay Area
- The Smart ProgramChairpersoncurrent2025 — present
- Paradox ImmunotherapeuticsExecutive Chaircurrent2024 — presentToronto, Ontario, Canada
- Compugen Ltd.Non Executive Directorcurrent2018 — presentTel Aviv District, Israel
- Bioqube VenturesStrategic Advisor2024 — 2026Belgium
- Symbiosis Capital ManagementOperating Advisor2023 — 2026Bentonville, Arkansas, United States
- Carisma TherapeuticsChairman of the Board2021 — 2025Philadelphia, Pennsylvania, United States
- ESSA PharmaceuticalsDirector2019 — 2025
- Kaerus Bioscience Ltd.Executive Chair2021 — 2023
- Janpix, Inc - a Centessa CompanyExecutive Chairman/Leadership Team2019 — 2022Boston, Toronto, London
- Palladio Biosciences, Inc., a Centessa companyFormer Chair- Current Consultant2019 — 2022Newton, PA
- MedicxiVenture Partner2020 — 2021
- IMIDomics, Inc.Chairman2015 — 2021Greater Barcelona Metropolitan Area
- Sydnexis Inc.Member Board Of Directors2020 — 2021Del Mar, California, United States
- Nuvelution Pharma, Inc.Co-Founder/Sr Advisor2019 — 2020Boston, Massachusetts
- Nuvelution Pharma, Inc.Founder and CEO2015 — 2019San Francisco Bay Area
- Realm Therapeutics, Inc.Non Executive Director2017 — 2019London, United Kingdom
- Lyric Pharmaceuticals, Inc.Chairman Board of Directors2015 — 2018San Francisco Bay Area
- Viventia Bio Inc.Member Board of Directors2015 — 2016
- Anthera PharmaceuticalsMember Board of Directors2013 — 2016
- Ascendancy Healthcare, Inc.CEO2010 — 2015San Francisco Bay Area
- Torreya Partners, LLCPrincipal2008 — 2010
- Reedland Capital PartnersManaging Director2005 — 2010
- Pathway DiagnosticsCEO & President2003 — 2005
- Bay City Capital, LLC / Bay City Capital BD, LLCManaging Director & CFO / President1997 — 2003
- Epoch Biosciences Corporation (formerly Microprobe Corporation) (Sold to Nanogen: NASDAQ – NGEN)President & CFO1995 — 1998
- D. Blech & Company, Inc.Managing Director1992 — 1995
- JS Frelinghuysen & Co. Inc.Vice President1989 — 1992
- Coopers & LybrandTax Specialist1987 — 1989
Skills & more
Private Equity16Strategy18Business Planning7Investments3Management6Leadership2Finance3Executive Management2Portfolio Management2Start-ups7BiotechnologyPharmaceutical Industry
+1 more
Venture CapitalFrom Sandy's professional profile.
Colleagues at Bioqube Ventures
Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Dirk Reyn
Managing Partner at Bioqube Ventures
Geert Tackaert
Finance Director at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Janine Schuurman
Senior Advisor at Bioqube Ventures
Jon Edwards
Managing Partner at Bioqube Ventures
Frequently asked questions
- Who is Sandy Zweifach?
- Sandy Zweifach is Chief Executive Officer of IMIDomics Inc. and serves as Chair and Board Member at other organizations. With over 30 years in life sciences, Zweifach has held CEO and President roles at three companies, raised more than $750 million in capital, and led mergers and acquisitions and licensing transactions valued at over $500 million, with experience spanning corporate partnerships, business development, and P&L management.
- Where does Sandy Zweifach work?
- Sandy Zweifach is Senior Advisor at Bioqube Ventures.
- Where did Sandy Zweifach go to school?
- Sandy Zweifach studied at UC San Diego (Bachelor of Arts (BA), Biology); University of California, Davis (Master of Science (MS), Human Physiology); Pace University (Accounting and Business Courses).
Same school
Also attended UC San Diego307
Elad GilSolo general partner investing through Gil CapitalMark SusterManaging Partner at Upfront VenturesChester NgGeneral Partner at AtomicBirgitteInvestor at InvestinorHouman HaghighiPartner, Business & Corporate Development at Menlo VenturesFreya Svedberg-KeatingInvestor at Medicxi
+ 301 more
Also attended University of California, Davis154
Charles CallSLP & Venture Partner at Cottonwood Technology FundDavid PhuController at Felicis VenturesBryan EglanDirector of Business Development at Menlo VenturesScott MaxwellInvestor at OpenView Venture PartnersMasoud AdinaHead of Compliance at GreycroftCraig MuirInvestor at Third Rock Ventures
+ 148 more
Also attended Pace University22
Jeffrey ChuaPartner at Golden Gate VenturesKrupa VankayalaPartner, People & HR at Sapphire VenturesSumesh SacharCo-founder & General Partner at Rocana VenturesTyler SchintoSenior Director at Presidio VenturesVarda KunzHuman Resources at TriplePoint CapitalLucile BeaumeSenior Associate at Breega
%20(1).png)
+ 16 more
Shared employers
Also worked at Bioqube Ventures15
Debora DumontManaging Partner at Bioqube VenturesDirk ReynManaging Partner at Bioqube VenturesNico VandervelpenManaging Partner at Bioqube VenturesJoris De MaeyerExecutive in Residence at Bioqube VenturesJoris VanderlochtChief Scientific Director at Bioqube VenturesAlexander DemoulinAssociate at Bioqube Ventures
+ 9 more
Also worked at Medicxi23
Francesco De RubertisInvestor at MedicxiGiovanni MariggiInvestor at MedicxiRichard LeeInvestor at MedicxiGiovanni PericoliniInvestor at MedicxiVictoria TaylorInvestor at MedicxiFrancois PrinslooInvestor at Medicxi
+ 17 more
